Hycamtin
Hycamtin ingredients
| Active ingredient | Strength |
|---|---|
| Topotecan Hydrochloride | 4 mg/4mL, 1 mg/1, .25 mg/1 |
What Hycamtin is used for
The FDA lists the approved uses on the official label (below). In the EU, topotecan is approved as Topotecan Hospira for:
Topotecan monotherapy is indicated for the treatment of patients with relapsed small-cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate. Topotecan in combination with cisplatin is indicated for patients with carcinoma of the cervix recurrent after radiotherapy and for patients with stage IVB disease. Patients with prior exposure to cisplatin require a sustained treatment-free interval to justify treatment with the combination.
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Hycamtin
- Generic name
- Topotecan hydrochloride
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Capsule, Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous, Oral
- Drug class
- Topoisomerase Inhibitor
- FDA approval
- New drug application (NDA) NDA020671
- On the US market since
- 2016
Official information
- Hycamtin prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Topotecan hydrochloride)
In India
- Topotecan hydrochloride: 4 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Hycamtin?
Hycamtin (Topotecan hydrochloride) is a cancer medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Hycamtin?
Hycamtin contains Topotecan Hydrochloride (4 mg/4mL, 1 mg/1, .25 mg/1).
Is Hycamtin approved in Europe?
The same active substance is approved in the EU as Topotecan Hospira, Hycamtin.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA